Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Class A Common Stock, par value $0.001 per share
-
Shares outstanding
-
64M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
13.6M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$88.1M
-
Value change
-
-$3.34M
-
Number of buys
-
36
-
Number of sells
-
-7
-
Price
-
$6.47
Significant Holders of Immuneering Corp - Class A Common Stock, par value $0.001 per share (IMRX) as of Q1 2022
50 filings reported holding IMRX - Immuneering Corp - Class A Common Stock, par value $0.001 per share as of Q1 2022.
Immuneering Corp - Class A Common Stock, par value $0.001 per share (IMRX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.6M shares
of 64M outstanding shares and own 21.28% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3.57M shares), Cormorant Asset Management, LP (2.3M shares), CITADEL ADVISORS LLC (2.16M shares), BlackRock Inc. (2.12M shares), VANGUARD GROUP INC (812K shares), PERCEPTIVE ADVISORS LLC (681K shares), GEODE CAPITAL MANAGEMENT, LLC (238K shares), FMR LLC (214K shares), SUVRETTA CAPITAL MANAGEMENT, LLC (200K shares), and STATE STREET CORP (176K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.